Drug Patents owned by Zealand Pharma

1. List of Zegalogue drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10442847 ZEALAND PHARMA Glucagon analogues
Feb, 2035

(11 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Mar 22, 2026

Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient

NCE-1 date: 2025-03-22

Market Authorisation Date: 22 March, 2021

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

ZEGALOGUE family patents

5

United States

3

Japan

2

Denmark

2

Korea, Republic of

2

China

2

European Union

1

Israel

1

South Africa

1

Mexico

1

Australia

1

Hong Kong

1

Philippines

1

Singapore

1

Argentina

1

Brazil

1

Malaysia

1

Spain

1

Poland

1

Taiwan, Province of China

1

India

1

Ukraine

EA

1

EA

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in